Literature DB >> 29945886

Molecular mechanisms of the preventable causes of cancer in the United States.

Erica A Golemis1, Paul Scheet2, Tim N Beck1,3, Eward M Scolnick4, David J Hunter5, Ernest Hawk6, Nancy Hopkins7.   

Abstract

Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United States alone. The public health burden associated with these numbers has motivated enormous research efforts into understanding the root causes of cancer. These efforts have led to the recognition that between 40% and 45% of cancers are associated with preventable risk factors and, importantly, have identified specific molecular mechanisms by which these exposures modify human physiology to induce or promote cancer. The increasingly refined knowledge of these mechanisms, which we summarize here, emphasizes the need for greater efforts toward primary cancer prevention through mitigation of modifiable risk factors. It also suggests exploitable avenues for improved secondary prevention (which includes the development of therapeutics designed for cancer interception and enhanced techniques for noninvasive screening and early detection) based on detailed knowledge of early neoplastic pathobiology. Such efforts would complement the current emphasis on the development of therapeutic approaches to treat established cancers and are likely to result in far greater gains in reducing morbidity and mortality.
© 2018 Golemis et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  cancer mechanisms; cancer prevention; early detection

Mesh:

Year:  2018        PMID: 29945886      PMCID: PMC6075032          DOI: 10.1101/gad.314849.118

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  318 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes.

Authors:  Fran Supek; Ben Lehner
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Authors:  Mark Schiffman; Walter K Kinney; Li C Cheung; Julia C Gage; Barbara Fetterman; Nancy E Poitras; Thomas S Lorey; Nicolas Wentzensen; Brian Befano; John Schussler; Hormuzd A Katki; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

Review 5.  Chronic obstructive pulmonary disease and lung cancer: new molecular insights.

Authors:  Ian M Adcock; Gaetano Caramori; Peter J Barnes
Journal:  Respiration       Date:  2011-03-24       Impact factor: 3.580

6.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

10.  Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Authors:  Marc Bourlière; Stuart C Gordon; Steven L Flamm; Curtis L Cooper; Alnoor Ramji; Myron Tong; Natarajan Ravendhran; John M Vierling; Tram T Tran; Stephen Pianko; Meena B Bansal; Victor de Lédinghen; Robert H Hyland; Luisa M Stamm; Hadas Dvory-Sobol; Evguenia Svarovskaia; Jie Zhang; K C Huang; G Mani Subramanian; Diana M Brainard; John G McHutchison; Elizabeth C Verna; Peter Buggisch; Charles S Landis; Ziad H Younes; Michael P Curry; Simone I Strasser; Eugene R Schiff; K Rajender Reddy; Michael P Manns; Kris V Kowdley; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2017-06-01       Impact factor: 91.245

View more
  34 in total

1.  Cancer prevention: Molecular and epidemiologic consensus.

Authors:  Mingyang Song; Bert Vogelstein; Edward L Giovannucci; Walter C Willett; Cristian Tomasetti
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

2.  Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.

Authors:  Alyssa N Troeschel; Terryl J Hartman; Eric J Jacobs; Victoria L Stevens; Ted Gansler; W Dana Flanders; Lauren E McCullough; Ying Wang
Journal:  J Clin Oncol       Date:  2020-04-06       Impact factor: 44.544

3.  A tel2 Mutation That Destabilizes the Tel2-Tti1-Tti2 Complex Eliminates Rad3ATR Kinase Signaling in the DNA Replication Checkpoint and Leads to Telomere Shortening in Fission Yeast.

Authors:  Yong-Jie Xu; Saman Khan; Adam C Didier; Michal Wozniak; Yufeng Liu; Amanpreet Singh; Toru M Nakamura
Journal:  Mol Cell Biol       Date:  2019-09-27       Impact factor: 4.272

4.  Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer.

Authors:  Christopher H Lieu; Erica A Golemis; Ilya G Serebriiskii; Justin Newberg; Amanda Hemmerich; Caitlin Connelly; Wells A Messersmith; Cathy Eng; S Gail Eckhardt; Garrett Frampton; Matthew Cooke; Joshua E Meyer
Journal:  Clin Cancer Res       Date:  2019-06-26       Impact factor: 12.531

5.  Profilin choreographs actin and microtubules in cells and cancer.

Authors:  Morgan L Pimm; Jessica Hotaling; Jessica L Henty-Ridilla
Journal:  Int Rev Cell Mol Biol       Date:  2020-07-16       Impact factor: 6.813

6.  Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer.

Authors:  Linara Gabitova-Cornell; Aizhan Surumbayeva; Suraj Peri; Janusz Franco-Barraza; Diana Restifo; Nicole Weitz; Charline Ogier; Aaron R Goldman; Tiffiney R Hartman; Ralph Francescone; Yinfei Tan; Emmanuelle Nicolas; Neelima Shah; Elizabeth A Handorf; Kathy Q Cai; Alana M O'Reilly; Ido Sloma; Rachel Chiaverelli; Richard A Moffitt; Vladimir Khazak; Carolyn Y Fang; Erica A Golemis; Edna Cukierman; Igor Astsaturov
Journal:  Cancer Cell       Date:  2020-09-24       Impact factor: 31.743

7.  RecQ DNA Helicase Rqh1 Promotes Rad3ATR Kinase Signaling in the DNA Replication Checkpoint Pathway of Fission Yeast.

Authors:  Nafees Ahamad; Saman Khan; Yong-Jie Xu
Journal:  Mol Cell Biol       Date:  2020-08-14       Impact factor: 4.272

Review 8.  Checkpoint functions of RecQ helicases at perturbed DNA replication fork.

Authors:  Nafees Ahamad; Saman Khan; Alaa Taha A Mahdi; Yong-Jie Xu
Journal:  Curr Genet       Date:  2021-01-11       Impact factor: 3.886

9.  A novel evolutionary-concordance lifestyle score is inversely associated with all-cause, all-cancer, and all-cardiovascular disease mortality risk.

Authors:  Alyssa N Troeschel; Terryl J Hartman; W Dana Flanders; Tomi Akinyemiju; Suzanne Judd; Roberd M Bostick
Journal:  Eur J Nutr       Date:  2021-03-06       Impact factor: 5.614

Review 10.  The Potential Health Benefits of the Ketogenic Diet: A Narrative Review.

Authors:  Kathryn Dowis; Simran Banga
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.